Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +3.63% | -12.82% | +15.09% |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Apr. 03 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 155M | Sales 2025 * | 169M | Capitalization | 97.91M |
---|---|---|---|---|---|
Net income 2024 * | -142M | Net income 2025 * | -102M | EV / Sales 2024 * | 0.63 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-0.7
x | P/E ratio 2025 * |
-0.98
x | Employees | 486 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.63% |
Latest transcript on FibroGen, Inc.
1 day | +3.63% | ||
1 week | -12.82% | ||
Current month | -56.60% | ||
1 month | -61.36% | ||
3 months | -7.27% | ||
6 months | +90.76% | ||
Current year | +15.09% |
Managers | Title | Age | Since |
---|---|---|---|
Thane Wettig
CEO | Chief Executive Officer | 59 | 20-06-21 |
Juan Graham
DFI | Director of Finance/CFO | 48 | 21-09-06 |
James Schoeneck
CHM | Chairman | 66 | 10-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 15-10-27 |
Director/Board Member | 59 | 15-08-05 | |
May Kin Ho
BRD | Director/Board Member | 71 | 18-12-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.83% | 1 M€ | 0.00% | - | |
0.13% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.02 | +3.63% | 1,257,557 |
24-04-24 | 0.9843 | -8.01% | 2,170,507 |
24-04-23 | 1.07 | -6.14% | 1,349,229 |
24-04-22 | 1.14 | -0.87% | 803,876 |
24-04-19 | 1.15 | -1.71% | 1,312,940 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.09% | 97.22M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- FGEN Stock